My areas of experience and focus ~
- Tumor immunology,
- Clinical Trials
- The Checkpoint Pathway
- The Patient Pathway
- Bridging the abyss beyond the diagnosis
The interaction and pathways between the immune system and tumors
Next-Generation Sequencing (NGS)
Discovering DNA & RNA sequences from biopsy tissue samples reveals the specific mutations that are driving cancer growth
The Checkpoint Pathway
Using the body’s own immune system to target & eliminate the mutations that are driving the cancer’s growth.
MMR/dMMR (d = deficient)
Mismatch Repair genes are our Body’s DNA Spell Checkers
MSI: Microsatellite Instability
Microsatellites are tracts of repetitive DNA –
Instability creates repetitive unchecked mistakes
PDL-1: Program Death Ligand 1
Checkpoint (Proteins) switch on or off an immune response
TMB – Tumour Mutational Burden
The number of mutations within a cancer growth
Medical Research meets patient research
So I am a little bit of a mix of all these things. I find myself at an intersection of topics that bring insights that can be applied to the Newly Diagnosed Patient’s ability to continue creating better quality responses to a serious cancer diagnosis.
We are also quickly improving how to translate and transition today’s best cancer knowledge & research breakthroughs into today’s Patient Choices.